安科瑞 reported revenue of ¥0.59B for the period ended 2026-06-30, +9.3% year on year. Net income was ¥0.11B, a 18.5% net margin on a 47.0% gross margin. The largest revenue line is 企业微电网系统及产品 at 98% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.59B | +9.3% |
| Gross profit | ¥0.28B | — |
| Operating income | ¥0.11B | — |
| Net income | ¥0.11B | -13.4% |
| Gross margin | 47.0% | Net margin 18.5% |
| Revenue Q/Q | +26.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 企业微电网系统及产品 | ¥0.58B | 97.9% |
| 电能服务业务 | ¥0.01B | 2.3% |
| 分部间抵销 | ¥-0.00B | -0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.31B | 53.0% |
| R&D | ¥0.07B | 11.2% |
| SG&A | ¥0.11B | 19.0% |
| Tax & other | ¥0.01B | 0.9% |
| Item | Amount |
|---|---|
| Total assets | ¥2.78B |
| Total liabilities | ¥0.50B |
| Shareholders' equity | ¥2.29B |
| Equity / assets | 82.2% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | -2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
飞利信 ・ 朗玛信息 ・ 利德曼 ・ ST荣科 ・ 百纳千成 ・ 吴通控股 ・ 蓝英装备 ・ 博雅生物 ・ *ST三六五 ・ 利亚德 ・ 三诺生物 ・ 富春股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies